TOP TIERMARKET NEWSWIRE
News & sentiment

ACUMEN PHARMACEUTICA (ABOS) — News & AI sentiment

ACUMEN PHARMACEUTICA (ABOS) news roundup. 4 stories in the past week, 6 over 30 days. Average 30-day sentiment is 55.2/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 1 sales totalling $75K — net selling of $75K. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
4
avg sentiment 55.3/100
30d stories
6
avg sentiment 55.2/100
Insider net (90d)
$75K
0 buys · 1 sells
Congress (90d)
0
0 buys · 0 sells

ABOS news in the last 24 hours, 7 days, 30 days and 90 days

How much ABOS coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowABOS storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days455.3/100ABOS headlines →
Last 30 days655.2/100ABOS headlines →
Last 90 days1954.9/100ABOS headlines →

Latest stories on ABOS

Acumen GSTI – Everpure
CNBC55 · neutralgeneral
4d ago
5d ago
5d ago
5d ago
Sep 2
Sep 2
Aug 12
Aug 12
Aug 12
Aug 12
Aug 12
Aug 12
Aug 12
Aug 12
Aug 5
Jul 16
Jul 7
Jul 7
Jun 17
Jun 16
Jun 16
Jun 16
Jun 9
Jun 3
Acumen's Late-2026 Sabirnetug Readout Is A Viable Bet
Seeking Alpha63 · neutralproduct/pr
May 20
Open ABOS in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →